Finance

Lists
Why is 000153 down 5.00%?
Dive Deeper
000153:SHE
Anhui Fengyuan Pharmaceutical Co., Ltd.
CNÂ¥4.75
-5.00%
(-0.25) 1D
Nov 20, 3:04:27 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000153...
Open
CNÂ¥4.96
High
CNÂ¥4.96
Low
CNÂ¥4.73
Mkt. cap
2.39B
Avg. vol.
8.35M
Volume
8.86M
Dividend
2.11%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
26.01
52-wk high
CNÂ¥7.35
52-wk low
CNÂ¥4.73
EPS
CNÂ¥0.18
Shares outstanding
464.69M
No. of employees
4K
Open
CNÂ¥4.96
High
CNÂ¥4.96
Low
CNÂ¥4.73
Mkt. cap
2.39B
Avg. vol.
8.35M
Volume
8.86M
Dividend
2.11%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
26.01
52-wk high
CNÂ¥7.35
52-wk low
CNÂ¥4.73
EPS
CNÂ¥0.18
Shares outstanding
464.69M
No. of employees
4K
News stories
From web sources and news partners
About Anhui Fengyuan Pharmaceutical Co., Ltd.
CEO-
Employees4.28K
FoundedAug 30, 1997
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebbcayy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
733.07M
835.92M
835.44M
752.25M
Cost of goods sold
580.93M
644.51M
665.86M
578.54M
Cost of revenue
580.93M
644.51M
665.86M
578.54M
Research and development expenses
4.77M
6.42M
14.34M
9.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
108.52M
129.73M
123.17M
117.83M
Operating expense
124.19M
140.58M
150.29M
135.39M
Total operating expenses
705.12M
785.09M
816.15M
713.93M
Operating income
27.95M
50.84M
19.29M
38.32M
Other non operating income
-3.08M
-376.70K
-230.38K
-378.36K
EBT including unusual items
11.23M
44.44M
30.26M
20.07M
EBT excluding unusual items
16.34M
45.18M
22.87M
31.20M
Income tax expense
14.64M
8.00M
-3.58M
6.12M
Effective tax rate
130.37%
18.01%
-11.84%
30.51%
Other operating expenses
421.98K
1.82M
12.40M
7.72M
Net income
-868.40K
37.01M
34.28M
14.45M
Net profit margin
-0.12%
4.43%
4.10%
1.92%
Earnings per share
-
-
-
-
Interest and investment income
365.49K
2.01M
11.70M
1.23M
Interest expense
-9.19M
-7.29M
-7.83M
-8.02M
Net interest expenses
-8.83M
-5.28M
3.86M
-6.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
58.19M
81.08M
48.96M
68.56M
Gain or loss from assets sale
326.42K
-
808.00
-808.00
Upcoming events
AI content may include mistakes. Learn more
Google apps